Welcome to the e-CCO Library!

search
Search by: 
Year: Category: Sub Type:
5: Medical treatment
Year: 2016
Source: 7th N-ECCO School
Authors: Hart A.
IBD nurse, 5-ASA, Adalimumab, Anti-TNF agents, Budesonide, Cetrolizumab, Corticosteroids, Golimumab, Infliximab, Methotrexate
Files: 1
5: Session 4: Disease-modification studies: Are we ready to start?
Year: 2016
Source: 2nd Advanced ECCO: EduCational COurse for Industry
Authors: Colombel J.
NATURAL HISTORY, TREAT TO TARGET
Files: 1
5: Status on e-health in IBD
Year: 2016
Source: 10th N-ECCO Network Meeting
Authors: Munkholm P.
FATIGUE, CALPROTECTIN
Files: 1
5: The microbiome and IBD
Year: 2016
Source: 14th IBD Intensive Advanced Course
Authors: Seksik P.
Ulcerative Colitis, Crohn's Disease, PROBIOTICS, FECAL MICROBIOTA TRANSPLANTATION
Files: 1
5: Tips & tricks for the IBD clinical research team
Year: 2016
Source: 1st School for Clinical Trialists
Authors: Schops G.
Last Modified: Wednesday, 15 March 2017, 4:44 PM by Vesna Babaja
Files: 1
5: What causes IBD?
Year: 2016
Source: 3rd Basic ECCO: EduCational COurse for Industry
Authors: Sturm A.
IMMUNOLOGY
Files: 1
60: Best abstract: Pharmacokinetics and exposure-response relationships of intravenously administered ustekinumab during induction treatment in patients with Crohn’s Disease: Results from the UNITI-1 and UNITI-2 studies
Year: 2016
Source: ECCO'16 Amsterdam
Authors: Adedokun O.
Crohn's Disease, pharmacokinetics, ustekinumab
Files: 1
62: Best abstract: Drug-concentration versus symptom-driven dose adaptation of infliximab in patients with active Crohn’s Disease: A prospective, randomised, multicentre trial (Tailorix)
Year: 2016
Source: ECCO'16 Amsterdam
Authors: D'Haens G.
Anti-TNF drug levels, therapeutic drug monitoring, anti-TNF agents
Files: 1
64: Care or action plans for patients
Year: 2016
Source: ECCO'16 Amsterdam
Authors: Andrews J., Kemp K.
patient choice, disease activity indices
Files: 1
65: Future of IBD healthcare in Europe
Year: 2016
Source: ECCO'16 Amsterdam
Authors: Hommes D.
health economic analysis, disease activity indices, cancer, clinical trials, complications, disability, disease activity, endoscopic assessment, fatigue, genetic, IBD, lymphoma, mucosal immunology, trough levels, Montréal classification, work
Files: 1
6: Adherence
Year: 2016
Source: 7th N-ECCO School
Authors: Bager P.
Crohn's disease, Ulcerative colitis, Patient reported outcomes, Quality of Life (IBDQ), Adherence to therapy
Files: 1
6: Advancement plasty for Crohns fistula
Year: 2016
Source: 5th S-ECCO IBD Masterclass
Authors: Serclova Z.
EUA, Crohn's Disease, perianal disease
Files: 1
6: Appendectomy
Year: 2016
Source: 3rd EpiCom Workshop
Authors: Munkholm P.
Crohn's Disease, Ulcerative Colitis, environment
Files: 1
6: Case based discussion: Investigation and management of mild/moderate Crohn’s Disease
Year: 2016
Source: 14th IBD Intensive Advanced Course
Authors: Raine T., Andrews J.
Crohn's Disease, Budenoside, Thiopurines (AZA / MP)
Files: 1
6: How is IBD diagnosed?
Year: 2016
Source: 3rd Basic ECCO: EduCational COurse for Industry
Authors: Calabrese E.
ULTRASOUND, MRI
Files: 1
6: IBD as a primary immune cell deficiency: Neutrophils and complement
Year: 2016
Source: Molecular aetiology of IBD
Authors: Boztug K.
neutrophil
Files: 1
6: Introduction to IBD-Character
Year: 2016
Source: EU Project Forum
Authors: Kalla R.
CRP, DIAGNOSIS
Files: 1
6: Methodology of cost efficacy
Year: 2016
Source: 5th ClinCom Workshop
Authors: Bodger K.
Last Modified: Wednesday, 15 March 2017, 5:09 PM by Vesna Babaja
health economic analysis
Files: 1
6: Microbiota research in IBD: State-of-the-art
Year: 2016
Source: 2nd Y-ECCO Basic Science Workshop
Authors: Sokol H.
microbiota, Crohn's Disease, Ulcerative Colitis
Files: 1
6: New dietary therapies in IBD
Year: 2016
Source: 1st D-ECCO Workshop
Authors: Sigall-Boneh R.
Crohn's Disease, Ulcerative Colitis, exclusive enteral nutrition, partial enteral nutrition
Files: 1